Mirae Asset Global Investments’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$34.9K Buy
2,331
+315
+16% +$4.72K ﹤0.01% 1305
2025
Q1
$36.2K Buy
2,016
+61
+3% +$1.09K ﹤0.01% 1300
2024
Q4
$46.3K Buy
+1,955
New +$46.3K ﹤0.01% 1274